Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington’s Disease Progression
Background: Huntington’s Disease (HD) is a monogenic neurodegenerative disease resulting in a CAG repeat expansion in the <i>HTT</i> gene. Despite this genetic simplicity, its molecular mechanisms remain highly complex. Methods: In this study, untargeted serum proteomics, bioinformatics...
Saved in:
| Main Authors: | Christiana C. Christodoulou, Christiana A. Demetriou, Eleni Zamba-Papanicolaou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-08-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/15/1195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis and validation of serum biomarkers in brucellosis patients through proteomics and bioinformatics
by: Xiao Li, et al.
Published: (2025-01-01) -
A collaborative network analysis for the interpretation of transcriptomics data in Huntington’s disease
by: Ozan Ozisik, et al.
Published: (2025-01-01) -
Proteome-Based Maternal Plasma and Serum Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis
by: Natalia Starodubtseva, et al.
Published: (2025-05-01) -
Recognizing familial Huntington's disease in an Asian cohort: Insights from the Philippines
by: Jao Jarro B. Garcia, et al.
Published: (2025-03-01) -
Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer
by: Mathilde Resell, et al.
Published: (2025-05-01)